Peripheral blood diagnostics (liquid biopsy), based on different genes and genetic products.
The company is developing diagnostic systems that could be useful such as:
Support for other diagnostic techniques.
A method of monitoring tumor progression and response to treatment.
A population screening test to detect sick individuals early without clinical manifestations.